Form 4 for CRIS CURIS INC
Accepted 2022-01-31 00:00:00 ET · period of report 2022-01-27 · accession 0001209191-22-005651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-31 | 2022-01-27+ | CRIS | Dentzer James E | Pres, CEO, Dir | S - Sale | $3.12 | -5,500 | 64.9K | -8% | -$17.1K |
| D | 2022-01-31 | 2022-01-29 | CRIS | Dentzer James E | Pres, CEO, Dir | A - Grant | $0.00 | +825.0K | 825.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-27 | S | D | 2,406 | $3.18 | 67,971 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-31 | S | D | 3,094 | $3.07 | 64,877 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2022-01-29 | A | A | 825,000 | $0.00 | 825,000 | D | $3.09 · — to 2032-01-28 | 825,000 Common stock | (F3) The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026. |